Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Mercks Keytruda achieves 24 percent response in bladder cancer study

      Merck's Keytruda achieves 24 percent response in bladder cancer study

      savita thakur thakur10 Oct 2016 9:53 AM IST
      Merck & Co's immunotherapy Keytruda proved effective as an initial treatment for nearly a quarter of patients with advanced bladder cancer too...
      Indian biosimilars market may reach $40 bn by 2030: Report

      Indian biosimilars market may reach $40 bn by 2030: Report

      savita thakur thakur9 Oct 2016 10:46 AM IST
      Hyderabad : Biosimilars presents a $240 billion global opportunity for Indian pharmaceuticals industry, while the domestic market is expected to reach...
      AstraZeneca licenses respiratory drug to Insmed

      AstraZeneca licenses respiratory drug to Insmed

      savita thakur thakur9 Oct 2016 10:33 AM IST
      Drugmaker Insmed Inc said it had bought the rights to an experimental early-stage respiratory drug from Britain's AstraZeneca Plc in a deal worth $150...
      Dr Reddys forays into Colombian market; to sell cancer drugs

      Dr Reddy's forays into Colombian market; to sell cancer drugs

      savita thakur thakur9 Oct 2016 10:33 AM IST
      New Delhi : Dr Reddy's Laboratories announced its entry into the Colombian market with its portfolio of cancer drugs."Our company has a track record...
      Lupin, MonoSol Rx sign pact for multiple pediatric products

      Lupin, MonoSol Rx sign pact for multiple pediatric products

      savita thakur thakur9 Oct 2016 9:33 AM IST
      New Delhi : Drug firm Lupin and US-based specialty pharmaceutical firm MonoSol Rx have signed a licensing agreement for multiple pediatric...
      Mercks Udit Batra Receives CEO of the Year Award from CPhI Pharma

      Mercks Udit Batra Receives CEO of the Year Award from CPhI Pharma

      savita thakur thakur8 Oct 2016 10:26 AM IST
      Germany : Merck, a leading science and technology company, announced that the CEO of its life science business, Udit Batra, was named "CEO of the...
      Roche gets boost from FDA in bid to expand uses for Actemra

      Roche gets boost from FDA in bid to expand uses for Actemra

      savita thakur thakur8 Oct 2016 10:26 AM IST
      The U.S. Food and Drug Administration has granted breakthrough status to Roche's rheumatoid arthritis medication Actemra for giant cell arteritis, the...
      Intas Pharmaceuticals Acquires the Generics Business of Actavis in UK, Ireland

      Intas Pharmaceuticals Acquires the Generics Business of Actavis in UK, Ireland

      savita thakur thakur8 Oct 2016 10:25 AM IST
      Intas Pharmaceuticals Ltd. through its wholly owned subsidiary Accord Healthcare Ltd., announced that it has entered into definitive agreements to...
      Merck directors Brijesh Kapil and Ali Sleiman resign

      Merck directors Brijesh Kapil and Ali Sleiman resign

      savita thakur thakur8 Oct 2016 9:24 AM IST
      New Delhi : Drug firm Merck Ltd said its whole time directors Brijesh Kapil and Ali Sleiman have resigned from the Board.Recently, Merck implemented...
      Court rejects Elder Pharma officials anticipatory bail plea

      Court rejects Elder Pharma official's anticipatory bail plea

      savita thakur thakur7 Oct 2016 1:20 PM IST
      New Delhi : A Delhi court rejected the anticipatory bail plea of COO of Elder Pharmaceuticals Anuj Saxena, accused of bribing former Ministry of...
      Sanofi awaits govt approval to launch dengue vaccine in India

      Sanofi awaits govt approval to launch dengue vaccine in India

      savita thakur thakur7 Oct 2016 1:18 PM IST
      Mumbai : After receiving authorization in 11 countries, Sanofi Pasteur is still awaiting for approval from the government to launch its dengue vaccine...
      Zydus group enters into in-licensing deal with Neovii

      Zydus group enters into in-licensing deal with Neovii

      savita thakur thakur7 Oct 2016 1:18 PM IST
      New Delhi : Ahmedabad based Zydus Group has entered into an in-licensing agreement with Switzerland-based Neovii to launch Grafalon, an immuno...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok